Cargando…
Changing the clinical course of glioma patients by preoperative motor mapping with navigated transcranial magnetic brain stimulation
BACKGROUND: Mapping of the motor cortex by navigated transcranial magnetic stimulation (nTMS) can be used for preoperative planning in brain tumor patients. Just recently, it has been proven to actually change outcomes by increasing the rate of gross total resection (GTR) and by reducing the surgery...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423137/ https://www.ncbi.nlm.nih.gov/pubmed/25884404 http://dx.doi.org/10.1186/s12885-015-1258-1 |
_version_ | 1782370157294780416 |
---|---|
author | Krieg, Sandro M Sollmann, Nico Obermueller, Thomas Sabih, Jamil Bulubas, Lucia Negwer, Chiara Moser, Tobias Droese, Doris Boeckh-Behrens, Tobias Ringel, Florian Meyer, Bernhard |
author_facet | Krieg, Sandro M Sollmann, Nico Obermueller, Thomas Sabih, Jamil Bulubas, Lucia Negwer, Chiara Moser, Tobias Droese, Doris Boeckh-Behrens, Tobias Ringel, Florian Meyer, Bernhard |
author_sort | Krieg, Sandro M |
collection | PubMed |
description | BACKGROUND: Mapping of the motor cortex by navigated transcranial magnetic stimulation (nTMS) can be used for preoperative planning in brain tumor patients. Just recently, it has been proven to actually change outcomes by increasing the rate of gross total resection (GTR) and by reducing the surgery-related rate of paresis significantly in cohorts of patients suffering from different entities of intracranial lesions. Yet, we also need data that shows whether these changes also lead to a changed clinical course, and can also be achieved specifically in high-grade glioma (HGG) patients. METHODS: We prospectively enrolled 70 patients with supratentorial motor eloquently located HGG undergoing preoperative nTMS (2010–2014) and matched these patients with 70 HGG patients who did not undergo preoperative nTMS (2007–2010). RESULTS: On average, the overall size of the craniotomy was significantly smaller for nTMS patients when compared to the non-nTMS group (nTMS: 25.3 ± 9.7 cm(2); non-nTMS: 30.8 ± 13.2 cm(2); p = 0.0058). Furthermore, residual tumor tissue (nTMS: 34.3%; non-nTMS: 54.3%; p = 0.0172) and unexpected tumor residuals (nTMS: 15.7%; non-nTMS: 32.9%; p = 0.0180) were less frequent in nTMS patients. Regarding the further clinical course, median inpatient stay was 12 days for the nTMS and 14 days for the non-nTMS group (nTMS: CI 10.5 – 13.5 days; non-nTMS: CI 11.6 – 16.4 days; p = 0.0446). 60.0% of patients of the nTMS group and 54.3% of patients of the non-nTMS group were eligible for postoperative chemotherapy (OR 1.2630, CI 0.6458 – 2.4710, p = 0.4945), while 67.1% of nTMS patients and 48.6% of non-nTMS patients received radiotherapy (OR 2.1640, CI 1.0910 – 4.2910, p = 0.0261). Moreover, 3, 6, and 9 months survival was significantly better in the nTMS group (p = 0.0298, p = 0.0015, and p = 0.0167). CONCLUSIONS: With the limitations of this study in mind, our data show that HGG patients might benefit from preoperative nTMS mapping. |
format | Online Article Text |
id | pubmed-4423137 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44231372015-05-08 Changing the clinical course of glioma patients by preoperative motor mapping with navigated transcranial magnetic brain stimulation Krieg, Sandro M Sollmann, Nico Obermueller, Thomas Sabih, Jamil Bulubas, Lucia Negwer, Chiara Moser, Tobias Droese, Doris Boeckh-Behrens, Tobias Ringel, Florian Meyer, Bernhard BMC Cancer Research Article BACKGROUND: Mapping of the motor cortex by navigated transcranial magnetic stimulation (nTMS) can be used for preoperative planning in brain tumor patients. Just recently, it has been proven to actually change outcomes by increasing the rate of gross total resection (GTR) and by reducing the surgery-related rate of paresis significantly in cohorts of patients suffering from different entities of intracranial lesions. Yet, we also need data that shows whether these changes also lead to a changed clinical course, and can also be achieved specifically in high-grade glioma (HGG) patients. METHODS: We prospectively enrolled 70 patients with supratentorial motor eloquently located HGG undergoing preoperative nTMS (2010–2014) and matched these patients with 70 HGG patients who did not undergo preoperative nTMS (2007–2010). RESULTS: On average, the overall size of the craniotomy was significantly smaller for nTMS patients when compared to the non-nTMS group (nTMS: 25.3 ± 9.7 cm(2); non-nTMS: 30.8 ± 13.2 cm(2); p = 0.0058). Furthermore, residual tumor tissue (nTMS: 34.3%; non-nTMS: 54.3%; p = 0.0172) and unexpected tumor residuals (nTMS: 15.7%; non-nTMS: 32.9%; p = 0.0180) were less frequent in nTMS patients. Regarding the further clinical course, median inpatient stay was 12 days for the nTMS and 14 days for the non-nTMS group (nTMS: CI 10.5 – 13.5 days; non-nTMS: CI 11.6 – 16.4 days; p = 0.0446). 60.0% of patients of the nTMS group and 54.3% of patients of the non-nTMS group were eligible for postoperative chemotherapy (OR 1.2630, CI 0.6458 – 2.4710, p = 0.4945), while 67.1% of nTMS patients and 48.6% of non-nTMS patients received radiotherapy (OR 2.1640, CI 1.0910 – 4.2910, p = 0.0261). Moreover, 3, 6, and 9 months survival was significantly better in the nTMS group (p = 0.0298, p = 0.0015, and p = 0.0167). CONCLUSIONS: With the limitations of this study in mind, our data show that HGG patients might benefit from preoperative nTMS mapping. BioMed Central 2015-04-08 /pmc/articles/PMC4423137/ /pubmed/25884404 http://dx.doi.org/10.1186/s12885-015-1258-1 Text en © Krieg et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Krieg, Sandro M Sollmann, Nico Obermueller, Thomas Sabih, Jamil Bulubas, Lucia Negwer, Chiara Moser, Tobias Droese, Doris Boeckh-Behrens, Tobias Ringel, Florian Meyer, Bernhard Changing the clinical course of glioma patients by preoperative motor mapping with navigated transcranial magnetic brain stimulation |
title | Changing the clinical course of glioma patients by preoperative motor mapping with navigated transcranial magnetic brain stimulation |
title_full | Changing the clinical course of glioma patients by preoperative motor mapping with navigated transcranial magnetic brain stimulation |
title_fullStr | Changing the clinical course of glioma patients by preoperative motor mapping with navigated transcranial magnetic brain stimulation |
title_full_unstemmed | Changing the clinical course of glioma patients by preoperative motor mapping with navigated transcranial magnetic brain stimulation |
title_short | Changing the clinical course of glioma patients by preoperative motor mapping with navigated transcranial magnetic brain stimulation |
title_sort | changing the clinical course of glioma patients by preoperative motor mapping with navigated transcranial magnetic brain stimulation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423137/ https://www.ncbi.nlm.nih.gov/pubmed/25884404 http://dx.doi.org/10.1186/s12885-015-1258-1 |
work_keys_str_mv | AT kriegsandrom changingtheclinicalcourseofgliomapatientsbypreoperativemotormappingwithnavigatedtranscranialmagneticbrainstimulation AT sollmannnico changingtheclinicalcourseofgliomapatientsbypreoperativemotormappingwithnavigatedtranscranialmagneticbrainstimulation AT obermuellerthomas changingtheclinicalcourseofgliomapatientsbypreoperativemotormappingwithnavigatedtranscranialmagneticbrainstimulation AT sabihjamil changingtheclinicalcourseofgliomapatientsbypreoperativemotormappingwithnavigatedtranscranialmagneticbrainstimulation AT bulubaslucia changingtheclinicalcourseofgliomapatientsbypreoperativemotormappingwithnavigatedtranscranialmagneticbrainstimulation AT negwerchiara changingtheclinicalcourseofgliomapatientsbypreoperativemotormappingwithnavigatedtranscranialmagneticbrainstimulation AT mosertobias changingtheclinicalcourseofgliomapatientsbypreoperativemotormappingwithnavigatedtranscranialmagneticbrainstimulation AT droesedoris changingtheclinicalcourseofgliomapatientsbypreoperativemotormappingwithnavigatedtranscranialmagneticbrainstimulation AT boeckhbehrenstobias changingtheclinicalcourseofgliomapatientsbypreoperativemotormappingwithnavigatedtranscranialmagneticbrainstimulation AT ringelflorian changingtheclinicalcourseofgliomapatientsbypreoperativemotormappingwithnavigatedtranscranialmagneticbrainstimulation AT meyerbernhard changingtheclinicalcourseofgliomapatientsbypreoperativemotormappingwithnavigatedtranscranialmagneticbrainstimulation |